Microbiology modernised at Bedford Hospital

The new technologies include a fully automated inoculation system, while KIESTRA InoqulA provides a largely end-to-end service to increase efficiency and reliability. This state-of-the-art system processes specimens in the most efficient way by automatically separating them into multiple cultures for testing. In addition, new urine and blood culture analysers will increase workload capacity and allow more tests to be carried out on an automated basis. GSTS Pathology is a joint venture between Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust and the Serco Group. It is one of the largest independent pathology organisations in the UK. For Bedford Hospital NHS Trust, the collaboration brings access to cutting-edge technology and the business development expertise of GSTS Pathology.
www.gsts.com